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Background and Objectives Interleukin 22 (IL22) is a pleio-
tropic cytokine with proinfl ammatory properties. It is primar-
ily expressed by T helper 17 (Th17) cells and has recently been 
implicated in the pathogenesis of collagen-induced arthritis, a 
murine model of autoimmune polyarthritis. The authors were 
able to demonstrate a pathogenetically dominant role of Th17 
cells and their signature cytokine IL17 in rheumatoid arthritis 
(RA) and psoriatic arthritis (PsA). Since the role of IL22 and its 
       
EWRR abstracts
Ann Rheum Dis 2010;69(Suppl 2):A1–A76A66
coordinate expression from Th17 cells in human autoimmune 
arthritis is unknown, our aim was to investigate IL22 in RA 
and PsA.
Methods and Results IL22 was analysed in well-defi ned 
cohorts of treatment-naive patients with active early RA and 
PsA. As control cohorts, the authors used healthy individuals 
(HC) and patients with osteoarthritis (OA). IL22 serum levels, 
measured by Enzyme-Linked Immunosorbant Assay, were 
highly elevated in RA patients compared with OA patients 
and HC. Comparably high levels of IL22 were detected in the 
synovial fl uid of RA patients. Surprisingly, IL22 was only mod-
estly elevated in the sera of PsA patients. Consistent with these 
fi ndings, the cellular analysis revealed increased frequencies of 
IL22-producing cells in activated CD4 T cells from RA but not 
from PsA patients, as assessed by three-colour fl ow cytometry. 
The increased frequency of IL22 positive cells was primarily 
attributed to the enrichment of IL22/IL17 double-positive cells. 
As priming of CD4 T cells under optimal Th17 cell-inducing 
conditions in vitro resulted in an increase of IL22/IL17 double 
producing cells at the cost of IL17 single producers when com-
pared with neutral priming conditions, the in vivo data from 
the patients suggest the presence of an environment facilitat-
ing biased Th17 cell development in RA but not in PsA.
Conclusion The data demonstrate increased IL22 expres-
sion and increased frequencies of IL17/IL22 double producing 
cells in RA. They therefore suggest the presence of an endog-
enous environment in RA promoting biased differentiation of 
infl ammatory Th17 cells.
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